This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ABT-981

AbbVie Inc.

Drug Names(s): ABT-981

Description: ABT-981 is a dual-variable domain Ig (DVD-Ig) that interleukin-1 (IL-1) alpha/beta. DVD-Ig is a proprietary Abbott technology representing an innovative approach that can target multiple disease-causing antigens with a single biologic agent.

ABT-981 News

Pink Sheet AbbVie Pays Big For Priority Review Voucher; Is Venetoclax The Target?

Pink Sheet Surveying The Landscape Of Bispecific Antibodies In Clinical Development

Scrip Abbott outlines pharma growth strategies

Scrip Drug-eluting Stents Present Headaches for Regulators

Additional information available to subscribers only:

Targets
Routes
Catalysts
Designations
Events

Request a Free Demo Subscriber Login Search for another drug